chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received 2nd dose, 5 months after the first dose in same facility.  Started to feel very tired by supper.  At 10-11pm started to feel nauseous, tried to throw up but could not until 1 hour latervomited 3 times.  Patient took usual medications at night: Vitamins, Eliquis, Lisinopril, and Singulair. In the morning, woke up and felt very achy on back so put heating pad on couch.  Started to feel nauseous again so went to the bathroom and could not throw up.  On the way back to the couch, a strange feeling came over, and fainted.  Patient hit head on washer/dryer when fell down; not sure how long was out.   Woke up and went back to lay on down, put heating pack on back and icepack on head.   At about 9: 30am, patient's
Minor neck and shoulder pains. Itching at rash on lower face, left and right side following third shot. Itchy rash on left temple area following fourth shot.  Follow up 05/30/2000: "Patient recovered from adverse event."
Trouble in his kidneys; pain; Feeling like he has the flu; Terrible thirsty; Breathing problems; This spontaneous case was reported by a consumer and describes the occurrence of RENAL DISORDER (Trouble in his kidneys), PAIN (pain), INFLUENZA (Feeling like he has the flu), THIRST (Terrible thirsty) and RESPIRATORY DISORDER (Breathing problems) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 52921a) for COVID-19 vaccination.     Concomitant products included "10-20 meds" and "asthma medication" for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced RENAL DISORDER (Trouble in his kidneys), PAIN (pain), INFLUENZA (Feeling like he has the flu), THIRST (Terrible thirsty) and RESPIRATORY DISORDER (Breathing problems). At the time of the report, RENAL DISORDER (Trouble in his kidneys), PAIN (pain), INFLUENZA (Feeling like he has the flu), THIRST (Terrible thirsty) and RESPIRATORY DISORDER (Breathing problems) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  Treatment information was not reported.
She had a sore arm after the first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received bnt162b2 (BNT162B2, solution for injection), administered in arm, administration date 04Jan2021 (Lot number: EL1284) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Arthritis" (ongoing), notes: Verbatim: Arthritis. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "She had a sore arm after the first dose". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information : No other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s). Family Medical History Relevant to AE(s): Initially states none.Then states her son was diagnosed with Lyme disease in Feb2020 right before the pandemic broke out. He recovered from the Lyme disease and was put on antibiotics. He has been suffering with symptoms like caller's every since. Her son's symptoms were not as bad all the caller's symptoms. Patient did not provide a product name for her son's antibiotics and no further details were provided.Infectious disease doctor checked for Lyme disease, which was negative.Immunologist did blood working checking antibody levels and all were normal. That was done in Aug2021.  Follow-up attempts are completed. No further information is expected.
temp to 39.2C 10DEC evening then to 38C 11DEC AM;only other sx faint rash <24hr & flushed face;
I have a round lesion that is raised and warm and about  3 inches in diameter at the injection site. EXTREMELY itchy!
Patient PASSED OUT. CAME BACK AFTER A FEW SECONDS. THEN 5 MINUTES LATER, PASSED OUT AGAIN. THEN PATIENT HAD A CONVULSION LASTING 3 SECONDS. AND THEN VOMITTED. 911 WAS CALLED
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI 3/8/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Fever temp reaching height of 102.2F, extreme light headedness/mild vertigo, incredibly high heart rate, quickened breathing (no shortness of breath), body temp of extremities quickly changing, strong shivering, nausea.  Mostly more severe instances of known side affects/symptoms.
Patient received first dose Pfizer and second dose Moderna. Patient had lost their vaccine card and confidently stated they had received the first dose of Moderna. As a result a second dose was given of Moderna only to find out later it had been Pfizer when the vaccine was being entered into IMMPACT
Td given IM right deltoid.  Redness, swelling, pain, lump under skin.  Mild local reaction.
Within 24 hours pt developed severe hives.  This started after he second vaccination. She has not responded to steroids, high dose antihistamines and h2 blockers. Singular was added.  She has continued to have increasing severity of hives. She has consulted two dermatologists without improvement
Report A0370296A describes pallor in a 10 y.o. male who received Hep B vaccine (manuf'r unknown). Medical history, concurrent conditions, and concurrent medications were not provided. In November 01, the subject received his first injection of Hep B vaccine ("may have been Engerix-B but not sure"). Reportedly, 15 mins after receiving the injection he experienced "dizziness, pale and, sick to stomach." Treatment was not specified. Info. received on 5/30/02 reports that all symptoms were resolved 1 day following the injection. Follow-up received from the physician on 9/10/02 specified that the events were reported to the physician by the mother and did not occur in his office. Since that episode, a 2nd Hep B vaccine was given to the subject by the physician in his office (date unspecified) "without any ill effect."
MENVEO was injected SQ instead of IM - caused pain & swelling at site.
tremors face arms & legs (severe) 25min BP 90/50, P80 155PM dizzy helped to floor;MD check pt;vagal response;
Received 1st shot 8/30/21. On 8/31/21 I had numbness, tingling all on  my right  side of the body. It started at my shoulder and went to my lower extremities. From there the  right sole of foot was hot and then burning. While having those symptoms, my vision was affected by unable to see anything, it would be a bright light and then blurred vision. All symptoms would last 2 to 3 seconds. This happened 6 to 7 times thoughtout the day and last for 1 week (9/5/21). Also had rapid heart rate and elevated blood pressure. Current symptoms are ringing in my right ear, vertigo and swollen bilateral glands on neck.
Pneumonia due to  COVID-19 virus; hypoxemia; type 2 diabetes mellitus with hyperglycemia with long-term current use of  insulin; hyponatremia; elevated troponin
about 1 min p/vax pt became unconscious snored loudly & voided incontinently; w/in several mins; pt was alert & talking BP 108/74; P110, R22; impression: adverse rxn to vax;
with ten minutes of vaccination, patient stated did not feel well, felt weak/tired, wanted to sleep (did not pass out  nor faint), pupils dilated, looked pale, after a few more minutes, patient started sweating, then was wide awake, pupils normal, stated felt fine/better just a little tired
Pt called this AM and stated that she was having problems with her arm. She had received a shot in it on Wednesday and she said that about 6 inches of her arm is red and swollen. She is wondering what to do about it. It old the patient to take some Benadryl if not allergic to it which it does appear that she is and use some compressions on it. I told that she was having an allergic reaction to the pneu. shot that she got an it should be better in a few days. She said that she would be fine.
chest pain; shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain) and DYSPNOEA (shortness of breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain) and DYSPNOEA (shortness of breath). At the time of the report, CHEST PAIN (chest pain) and DYSPNOEA (shortness of breath) outcome was unknown.            No Concomitant drugs were reported.  No Treatment medications were reported.   Reporter did not allow further contact
This spontaneous report was received from a licensed practical nurse, referring to a 19 year old, male patient. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On unknown dates the patient was vaccinated with the three dose series of GARDASIL (dose, route, lot # and expiration date were not reported). Then, on 01-SEP-2015, the patient was vaccinated with an additional dose of GARDASIL 9 by intramuscular route in the right arm (reported as RD), lot # K026247 (expiration date was not reported), because a company representative mistakenly told that it was the Centers for Disease Control and Prevention (CDC) recommendation. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information has been received.
Information has been received from a licensed practical nurse concerning a 46 year old male with type 1 diabetes mellitus, and no history of drug reactions/allergies. In 1994, the patient received first vaccination with Pneumovax 23. On 02-APR-2007, the patient was vaccinated with second dose of Pneumovax 23 (lot # 655152/0889F) 0.5 ml IM in the left deltoid. Concomitant therapy included ADACEL also given on 02-APR-2007 in the right arm. On 03-APR-2007, the patient experienced muscle aching and called the office. On 04-APR-2007, the patient was seen in the office with a fever of 100.4 degrees Fahrenheit (F). His left arm had a 8x8 area of induration. His fever had risen to 103 F with chills and sweating. He was placed on cephalahexin for 7 days. When he called the office on 06-APR-2007, his temperature had decreased to 98 F and the redness was decreased. On 10-APR-2007, at the time of reporting, he had recovered. The nurse reported that the muscle aching, fever, induration, chills, sweats, and redness were other Important Medical Events and they were disabling because the patient missed work. Additional information has been requested.
A male physician reported that 2 days after he received FluMist on Oct 11 2005, he experienced low grade fever, chills and myalgia. On Oct 17 2005, he noted that he had a fever of 103 degrees Farenheit and he started to cough. A chest x ray was performed (date unspecified) and revealed pneumonia. He was treated with combination of amantadine and Levaquin (levofloxacin). The patients clinical outcome was unknown at the time of report. The reporter causality is not provided. Follow up - This is a non serious spontaneous case from a physician involving pneumonia. The reporter causality is not provided. This case is submitted according to VAERS Surveillance accelerated reporting agreement for FLUMIST. A 31-year-old male physician reported that 2 days after he received FLUMIST on 11Oct2005, he experienced low grade fever, chills and myalgias. On 17Oct05, he noted that he had a fever of 103 degrees Farenheit and he started to cough. A chest x-ray was performed that revealed pneumonia. He was treated with a combination of amantadine and LEVAQUIN. The event is considered resolved. The reporter causality is not provided.
I do not have the time to fill this out. I have a rash all over my body .that started about 10 days after I got  Moderna Covid-19  shot #2
p/vax pt exp mild varicella type rash & visited the ER;the rash consisted of approx 15 lesions;
suspected vaccination failure/Got the vaccine last year, now I have shingles; Shingles/ Now i have shingles; It is miserable; It is painful; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In October 2022, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, feeling miserable and pain. On an unknown date, the outcome of the vaccination failure, feeling miserable and pain were unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, feeling miserable and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 9-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient got the vaccine last year, but now had shingles. The patient stated that it was miserable and painful. The patient wishes that the vaccine was 100 percent effective, but it's not. The reporter denied to follow-up. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. As the reporter was describing shingles as it was miserable and painful therefore onset date for both event was captured as October 2022 same as shingles.
Patient was given  a vaxcellis vaccine instead of the Tdap vaccine that was ordered.
I21.4 ACUTE NON ST ELEVATION MI 11/27/2021 ATRIAL FIBRILLATION, PAROXYSMAL
Starting 2MAR92 pt irritable, no appetite, felt warm to mom; & on 4MAR92 rash on trunk & face; 5MAR92 rash over entire body;
Patient was leaning on back shelf, doubled over, I walked over and asked if she was ok, she said she wasn't and collapsed to the floor.  Patient was responsive to external stimuli and 911 was immediately called.  I stayed with her while staff alerted store management to the incident, patient was responsive to external stimuli the whole time, complained of LLQ abdominal pain. EMT arrived on scene and tested blood sugar, first read was 28, glucagon and glucose paste administered, second test 83.  Patient responsive, and taken to Hospital.  Mother, sister and manager on duty alerted
PATIENT WAS GIVEN VACCINE PER ALL GUIDLEINES, PATIENT TOLERATED WELL, BUT THEN GOT HOT AND PASSED OUT, FATHER ASSISTED AND CHILD THREW HIS HEAD BACK AGAINST WALL. FATHER AND I FANNED AND OBSERVED CHILD AND HE CAME TO . HE VOMITED AND THEN ASKED FOR A DRINK. AFTER RESTING FOR ABOUT 10 MINUTES CHILD WAS ABLE TO STAND AND DO JUMPING JACKS. I CALLED FATHER AROUNF 7PM AND CHILD HAD RETURNED TO NORMAL ACTIVITIES AND WAS FINE, ADVISED FATHER TO CALL ME IF NEEDED.
Mild swelling of right thigh at injection site (MMR). Seen by DR. Benadryl 125/5 1tsp PO given and Tylenol 240mg PO given at 11:25, mild redness and swelling left thigh inj site.
Arm is painful, & limited mobility. Decrease range of motion. MD prescribed Diclofenac - TID dosing.
Admitted 8/24/21 with COVID PNA, remains hospitalized on 8/25/21.  Currently receiving remdesivir, requiring 3L O2.  Began having symptoms 8/19/21.
Presented to our hospital with evaluation of blurred vision that started 2 days ago. No symptoms for COVID-19 but test came back positive.
GOT COVID; HEALTH ISSUES; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced got covid, and health issues. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got covid and health issues was not reported. This report was non-serious. This report was associated with product quality complaint 90000279707.
Swelling and redness at site of varicella vaccine.  Mild myalgias.  No SOB or throat tightness.  Left upper arm warm to touch with moderate effusion over tricep area.  No streaking or axillary LAP.
On 4/17 midday, I experienced body aches and headaches. Later in the day I had a fever of 101. On 4/18 I felt dizziness and a headache only. The dizziness and headache has been ongoing since 4/18/21.  Today 4/23, I still have dizziness, its not as bad but it continues.
Reported 11/4/02 approximately 3-4 hrs after injection pt had chills for 2 hrs, then became warm, pain throughout back and weakness. Pt states she had a racing heart beat about 7 hrs after the shot. States by morning 11/1/02 at 8am heart rate was better. Pt discussed with nurse at MD's office on 11/1/02 her symptoms. Advised to contact MD office or go to ER if symptoms persist. MD office notified by RN.
Patient  after receiving the 1st dose of vaccine  and was monitored  for 15 mins during which no adverse reaction was noted or reported . About ten minutes after the patient left  the facility  she returned with complaint of throat discomfort.  V/S was done and elevated blood pressure noted.  Pt was evaluated by provider on site  and Benadryl  50 ml IM was administered, Patient was evaluated for another 50 minutes during which she reported that she felt better.  Her v/s was done  again and was stable. Pt was alert and oriented x4  with no c/o of worsening symptoms . she drank water with no complaints. She was advised to go to the nearest ER or call emergency should she develop and shortness of breath  or any other reaction. Patient verbalized understanding of the information given .
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No medical history and concurrent conditions of the patient were reported. On 10-AUG-2015, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX (lot number: K003407 and expiry date: 06-MAR-2016)(dose, frequency and route not reported). No concomitant medications were reported. No adverse experiences were reported. No product quality complaint (PQC) was filed. The outcome of incorrect product storage was unknown. This is one of several reports of the same reporter. Additional information has been requested.
Injection hurt immediately. After 6 hours , back of neck began to hurt and started to become tired. Took 1000mg Tylenol at 6pm. At midnight, took next dose of Tylenol but did not have any relief, became feverish and tired. Felt feverish, tired all the next day. Also developed rash at injection site that lasted 3 days and went away after taking 1/2 Benadryl pill.
Patient came to pharmacy 11 AM 11-15-13 ZOSTAVAX left arm 11-14-13 but on right wrist has red rash. Patient states red, hot, itchy - patient to see her doctor 11-15-13 at 1 PM.
Patient normally feels what he describes as queasy after any event involving a needle. Today he started to feel queasy after immunization. Pharmacist stayed with him, placed him on the floor and gave him an icepack and a basket incase he got sick. He laid down on floor for about 10 minutes with ice pack on neck. Felt better to sit up for 5 minutes and then wanted to move to chair in post IMZ area for 5 more minutes. He felt good enough to leave after 30 minutes post vaccination. Will all tomorrow for follow up.
drenched with sweat; doesn't feel well; arm is red; itchy; still dizzy; swollen; arm hurts; headache; completely wiped out; horrible chills; body aches; high fever; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (drenched with sweat), ILLNESS (doesn't feel well), ERYTHEMA (arm is red), PRURITUS (itchy) and DIZZINESS (still dizzy) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in September 2020. Concurrent medical conditions included Hypertension.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced ILLNESS (doesn't feel well), ERYTHEMA (arm is red), PRURITUS (itchy), DIZZINESS (still dizzy), PERIPHERAL SWELLING (swollen), PAIN IN EXTREMITY (arm hurts), HEADACHE (headache), FATIGUE (completely wiped out), CHILLS (horrible chills), MYALGIA (body aches) and PYREXIA (high fever). On 28-Mar-2021, the patient experienced HYPERHIDROSIS (drenched with sweat). On 27-Mar-2021, HEADACHE (headache), FATIGUE (completely wiped out), CHILLS (horrible chills), MYALGIA (body aches) and PYREXIA (high fever) had resolved. At the time of the report, HYPERHIDROSIS (drenched with sweat) outcome was unknown and ILLNESS (doesn't feel well), ERYTHEMA (arm is red), PRURITUS (itchy), DIZZINESS (still dizzy), PERIPHERAL SWELLING (swollen) and PAIN IN EXTREMITY (arm hurts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure medication. No treatment information was reported.
Face paralyzed; Guillain barre syndrome; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PARALYSIS (Face paralyzed) and GUILLAIN-BARRE SYNDROME (Guillain barre syndrome) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FACIAL PARALYSIS (Face paralyzed) (seriousness criterion medically significant) and GUILLAIN-BARRE SYNDROME (Guillain barre syndrome) (seriousness criterion medically significant). At the time of the report, FACIAL PARALYSIS (Face paralyzed) and GUILLAIN-BARRE SYNDROME (Guillain barre syndrome) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment for the events were not provided. The caller stated he knows another person who had his face paralyzed due to Guillain barre syndrome 2 weeks after the shot.  Company Comment: Very limited information regarding these events has been provided at this time. No further information is expected.; Sender's Comments: Very limited information regarding these events has been provided at this time. No further information is expected.